ICRF 159 plus radiation versus radiation therapy alone in cervical carcinoma: A double-blind study

C. Belloni, C. Mangioni, G. Bortolozzi, S. Carinelli, M. D'Incalci, A. Maggioni, L. Morasca

Research output: Contribution to journalArticlepeer-review

Abstract

In a double-blind trial the effect of ICRF 159 or placebo associated with radiotherapy was compared in 70 patients with cervical carcinoma. No significant differences were found on histopathological examination of surgical specimens obtained 6 weeks after the end of the treatment. Clinical evaluation after a follow-up of 46 ± 5 months, also showed no significant effect of ICRF 159 with radiotherapy.

Original languageEnglish
Pages (from-to)181-185
Number of pages5
JournalOncology
Volume40
Issue number3
DOIs
Publication statusPublished - 1983

Keywords

  • Cervical carcinoma
  • ICRF 159 (Raxozane®)
  • Potentiation of radiotherapy
  • Radiation therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'ICRF 159 plus radiation versus radiation therapy alone in cervical carcinoma: A double-blind study'. Together they form a unique fingerprint.

Cite this